News | July 28, 2015

FDA Approves The ReShape™ Integrated Dual Balloon System, a First-Of-Its-Kind Non-Surgical Weight Loss Procedure for People with Mild to Moderate Obesity – Next generation dual balloon designed to create a feeling of fullness while providing patient comfort and...

News | July 23, 2015

Chimerix Announces Positive Topline Results From Brincidofovir Pivotal Study in Animal Model for Smallpox Data Demonstrated Statistically Significant Survival Benefit DURHAM, N.C., July 23, 2015 (GLOBE NEWSWIRE) — Chimerix, Inc. (NASDAQ:CMRX), a...

News | July 22, 2015

QPID Health sequences the “digital DNA” in your health record Alvin Yu, MD, Clinical Content Engineer – July 22, 2015 – As an engineer turned physician who returned to engineering as a QPID clinical content engineer (yes, it’s confusing!), I’ve been...

News | July 8, 2015

Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing – Funds to advance pipeline, and clinical lead AF-219 for the treatment of pathologic cough, including in idiopathic pulmonary fibrosis (IPF) patients – SAN MATEO,...

News | January 2, 2013

Relypsa Announces Agreement with FDA on Special Protocol Assessment for Patiromer Phase 3 Trial for the Treatment of Hyperkalemia According to data reported at Kidney Week 2012, an ongoing Phase 2b study of patiromer met the interim analysis primary endpoint of mean...